RxDoctor Payments Data

Nicole Morgan, APRN

Family · Las Vegas, NVNPI 1609519792

Payments from drug & device makers

$1,980in general payments, 2019–2025

Across 103 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$331
  • AbbVie$324
  • GSK$193
  • Amgen$150
  • Pfizer$133
  • AstraZeneca$110
  • plus $739 from 21 others

What the payments were for

  • Food & beverage$1,980100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,980 in reported general payments places this provider in the 80th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Medicare billing

Part B allowed, 2024
$87,054
Medicare patients
286
Services billed
1,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin17$18,949
LinzessLinaclotide11$10,090
EliquisApixaban11$9,767
Ventolin HfaAlbuterol Sulfate13$729
Omeprazole36$640
Atorvastatin Calcium76$573
Albuterol Sulfate HfaAlbuterol Sulfate30$533
Gabapentin19$388
Metformin Hcl29$301
Pantoprazole Sodium35$295
Losartan Potassium38$248
Metoprolol Succinate19$230
Famotidine12$213
Lisinopril31$210
Ezetimibe11$165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$22$18,94917 claims
AbbVieLinzess$324$10,09011 claims
PfizerEliquis$133$9,76711 claims
Almatica Pharma LLCSertraline Hcl$16$9916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,501 family providers in Nevada.

Other family in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →